These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27312068)

  • 1. The polyglutamine-expanded androgen receptor responsible for spinal and bulbar muscular atrophy inhibits the APC/C(Cdh1) ubiquitin ligase complex.
    Bott LC; Salomons FA; Maric D; Liu Y; Merry D; Fischbeck KH; Dantuma NP
    Sci Rep; 2016 Jun; 6():27703. PubMed ID: 27312068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.
    Lu L; Hu S; Wei R; Qiu X; Lu K; Fu Y; Li H; Xing G; Li D; Peng R; He F; Zhang L
    J Biol Chem; 2013 Dec; 288(50):35637-50. PubMed ID: 24163370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA.
    Karliner J; Liu Y; Merry DE
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2321408121. PubMed ID: 38976730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Nuclear Export of Polyglutamine-Expanded Androgen Receptor in Spinal and Bulbar Muscular Atrophy.
    Arnold FJ; Pluciennik A; Merry DE
    Sci Rep; 2019 Jan; 9(1):119. PubMed ID: 30644418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.
    Orr CR; Montie HL; Liu Y; Bolzoni E; Jenkins SC; Wilson EM; Joseph JD; McDonnell DP; Merry DE
    J Biol Chem; 2010 Nov; 285(46):35567-77. PubMed ID: 20826791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergic prodegradative activity of Bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy.
    Giorgetti E; Rusmini P; Crippa V; Cristofani R; Boncoraglio A; Cicardi ME; Galbiati M; Poletti A
    Hum Mol Genet; 2015 Jan; 24(1):64-75. PubMed ID: 25122660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy.
    Palazzolo I; Nedelsky NB; Askew CE; Harmison GG; Kasantsev AG; Taylor JP; Fischbeck KH; Pennuto M
    J Neurosci Res; 2010 Aug; 88(10):2207-16. PubMed ID: 20336775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.
    Renier KJ; Troxell-Smith SM; Johansen JA; Katsuno M; Adachi H; Sobue G; Chua JP; Sun Kim H; Lieberman AP; Breedlove SM; Jordan CL
    Endocrinology; 2014 Jul; 155(7):2624-34. PubMed ID: 24742193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy.
    Pluciennik A; Liu Y; Molotsky E; Marsh GB; Ranxhi B; Arnold FJ; St-Cyr S; Davidson B; Pourshafie N; Lieberman AP; Gu W; Todi SV; Merry DE
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33170804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking the dimerization of polyglutamine-expanded androgen receptor protects cells from DHT-induced toxicity by increasing AR turnover.
    Lisberg A; Liu Y; Merry DE
    J Biol Chem; 2024 May; 300(5):107246. PubMed ID: 38556081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome-mediated proteolysis of the polyglutamine-expanded androgen receptor is a late event in spinal and bulbar muscular atrophy (SBMA) pathogenesis.
    Heine EM; Berger TR; Pluciennik A; Orr CR; Zboray L; Merry DE
    J Biol Chem; 2015 May; 290(20):12572-84. PubMed ID: 25795778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxic effects of androgens in spinal and bulbar muscular atrophy.
    Parodi S; Pennuto M
    Front Neuroendocrinol; 2011 Oct; 32(4):416-25. PubMed ID: 21745497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal and Bulbar Muscular Atrophy Overview.
    Fischbeck KH
    J Mol Neurosci; 2016 Mar; 58(3):317-20. PubMed ID: 26547319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-Linked Spinal and Bulbar Muscular Atrophy: From Clinical Genetic Features and Molecular Pathology to Mechanisms Underlying Disease Toxicity.
    Cortes CJ; La Spada AR
    Adv Exp Med Biol; 2018; 1049():103-133. PubMed ID: 29427100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
    Adachi H; Waza M; Tokui K; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
    J Neurosci; 2007 May; 27(19):5115-26. PubMed ID: 17494697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.
    Pennuto M; Basso M
    J Mol Neurosci; 2016 Mar; 58(3):365-73. PubMed ID: 26614347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal and autophagic degradative activities in spinal and bulbar muscular atrophy.
    Rusmini P; Bolzoni E; Crippa V; Onesto E; Sau D; Galbiati M; Piccolella M; Poletti A
    Neurobiol Dis; 2010 Nov; 40(2):361-9. PubMed ID: 20621188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
    Baniahmad A
    J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anaphase promoting complex induces substrate degradation during neuronal differentiation.
    Harmey D; Smith A; Simanski S; Moussa CZ; Ayad NG
    J Biol Chem; 2009 Feb; 284(7):4317-23. PubMed ID: 19047054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
    Pennuto M; Rinaldi C
    Mol Cell Endocrinol; 2018 Apr; 465():113-121. PubMed ID: 28688959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.